Evidence map›Paper›PMID 41963074›Full record

SynthesisBMJ open respiratory research2026

What is the evidence for virtual wards or hospital-at-home care pathways for exacerbations of chronic obstructive pulmonary disease? A systematic review and meta-analysis.

Bushra Alenazi, Christopher Hatton, Elizabeth Sapey

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bushra AlenaziRespiratory Care-College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Jubail, Saudi Arabia bushra.alenazi@gmail.com.ORCID http://orcid.org/0009-0008-5177-4889
Christopher HattonNIHR Midlands Patient Safety Research Collaboration, Department of Inflammation & Ageing, College of Medicine and Health, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK.ORCID http://orcid.org/0009-0004-2996-6711
Elizabeth SapeyNIHR Midlands Patient Safety Research Collaboration, Department of Inflammation & Ageing, College of Medicine and Health, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK.ORCID http://orcid.org/0000-0003-3454-5482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesGiven increasing interest in admission avoidance, we evaluated the evidence to support virtual wards (VW) and hospital at home (HaH) models of care during exacerbations of chronic obstructive pulmonary disease (ECOPD).

designA systematic review and meta-analysis. A comprehensive search of MEDLINE (1946 to March 2024), Embase (1974 to March 2024) and CENTRAL (searched 22 March 2024) was conducted. Risk of bias and a random effects meta-analysis were performed. POPULATION: Adults with an ECOPD presenting to the hospital or who require hospital-led care.

interventionsVW: defined as assessments and interventions delivered remotely or HaH (defined as assessments and interventions delivered by healthcare professionals in patient's homes) care pathways, compared with hospital admission. PRIMARY AND SECONDARY

objectivesSafety (mortality rate of all causes, in-patient, 7 days and 30 days) and readmission rate in 7 and 30 days. Length of stay in hospital and changes in pulmonary function tests.

resultsOne study assessed VWs (reported in two publications) and 10 assessed HaH. There were no changes in survival or short-term readmission rates attributable to the interventions and no evidence that VW or HaH care pathways reduced the total time a patient spent under hospital-led care, whether at home or in the hospital.

conclusionsMore evidence is needed to support the widespread roll-out of HaH and especially VW pathways for ECOPD. PROSPERO REGISTRATION NUMBER: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024517565.

Indexed as

Home Care Services, Hospital-BasedPulmonary Disease, Chronic ObstructiveCritical PathwaysDisease ProgressionHome Care ServicesHospitalizationHumansLength of StayPatient ReadmissionTelemedicineCOPD Exacerbations

Identifiers

PMID41963074
PMCPMC13084816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.